354 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (95)
- Autoimmune Disorders (4)
- Blood Disorders (2)
- Bone & Muscle (1)
- Cancer (52)
- COVID-19 (Coronavirus) (1)
- Diabetes (1)
- Healthy Volunteers (1)
- Heart Disease (3)
- Kidney Disease (12)
- Liver Disease (3)
- Lung Disease (1)
- Neurological Disorders (1)
- Obesity (1)
- Surgery (1)
- Transplant (10)
- Vascular Conditions (1)
Displaying 1 - 2 of 2
A study for kidney transplant subjects using study drug eculizumab to prevent delayed graft function
Condition: Transplant / Liver Transplant
Investigator: Lloyd Ratner, MD, MPH, FACS
Status: Closed
The purpose of this study is to determine if eculizumab is safe and could be used to prevent Delayed Graft Function (DGF) following kidney transplantation. DGF is an early complication of kidney transplantation. This condition occurs when the transplanted kidney…
Condition: Cancer / Leukemia
Investigator: Ran Reshef, MD
Status: Closed
Patients who will be receiving immune effector cell (IEC) therapy for the treatment of their cancer (leukemia) are being asked to participate in this study. IEC can produce a harmful side effect called Cytokine Release Syndrome (CRS). CRS involves a release of a large amount of proteins into the bloodstream. This may cause changes in blood pressure and…
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website,
you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the
Columbia University Website Cookie Notice.
I AGREE